Evaluation of the Individual Early Psychoeducation Program for Schizophrenic Disorders in Inpatients
NCT ID: NCT05329363
Last Updated: 2024-04-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
200 participants
INTERVENTIONAL
2022-06-17
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Psychoeducation can improve therapeutic alliance and medication compliance.
In this context, an individual psycho-education program (PEPITS) has been developed. PEPITS carried out by nurses during the initial stages of hospitalisation.
The hypothesis is that PEPITS program will decrease relapse and improve the compliance and insight and and so the quality of life.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Psychoeducation Program for Families Caregivers of Schizophrenic Patients : Randomized Study in Two Arms
NCT03000985
Study of the Impact on the Therapeutic Alliance of a Short Initial Psychoeducation Programme in Patients With Early Schizophrenia
NCT04867681
Peer-led Psycho-education for Schizophrenia
NCT03246932
Medication Adherence in Schizophrenia: Development of a CBT-Based Intervention
NCT00980252
Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry
NCT01611337
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PEPITS programme
PEPITS Programme
The programme has three main phases:
Phase I: Introduction phase (Session 1) Phase II: Pathology and care work phase (Sessions 2 - 3 - 4) Phase III: Recovery and "stepping stone" phase (Sessions 5 - 6 - 7) The programme provides information, keys and new skills to the patient through 3 phases focusing on pathology and recovery.
Usual care
Usual care
Patients will receive the same psychiatric care as the experimental group except of the PEPITS programme.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PEPITS Programme
The programme has three main phases:
Phase I: Introduction phase (Session 1) Phase II: Pathology and care work phase (Sessions 2 - 3 - 4) Phase III: Recovery and "stepping stone" phase (Sessions 5 - 6 - 7) The programme provides information, keys and new skills to the patient through 3 phases focusing on pathology and recovery.
Usual care
Patients will receive the same psychiatric care as the experimental group except of the PEPITS programme.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with a diagnosed and reported schizophrenic disorder announced :
* Schizophrenia
* Schizoaffective disorder
* Or a diagnosed and reported Delusional Disorder
* Express written consent by the participant after receiving information about the study
* Be able to communicate verbally
* Participant affiliated to a social security scheme
Exclusion Criteria
* Patient who does not speak French
* Participation in a psycho-education group in the last 2 years
* Patient under legal protection or guardianship
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Tours
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Serrvice de Psychiatrie
Blois, , France
Service de psychiatrie
Chinon, , France
Service de psychiatrie
Dreux, , France
Service de psychiatrie
Fleury-les-Aubrais, , France
Service de psychiatrie
La Roche-sur-Yon, , France
Service de psychiatrie
Neuilly-sur-Marne, , France
Service de psychiatrie
Rennes, , France
Service de psychiatrie
Saint-Maurice, , France
Service de psychiatrie
Sainte-Gemmes-sur-Loire, , France
Service de psychiatrie
Sotteville-lès-Rouen, , France
Service de psychiatrie
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jessica PÉTÉ SARAROLS
Role: primary
Mathilde JOUIN
Role: primary
Aurélie FLORENTIN
Role: primary
Béatrice SURGET
Role: primary
Damien CROGUENNEC
Role: primary
Efflam BREGEON
Role: primary
Hélène LECUYER
Role: primary
Alex MONDOULET
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DR190062
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.